Company profile MRNS

Marinus Pharmaceuticals Inc
marinus pharmaceuticals is a clinical stage biopharmaceutical company dedicated to positively impacting the well-being of patients who suffer from epilepsy and neuropsychiatric disorders. the company is in the midst of developing and commercializing ganaxolone which will treat adults and children with epileptic seizures and women with postpartum depression. on june 29, 2017, th...e company announced that the u.s. food and drug administration (fda) granted orphan drug designation to ganaxolone for the treatment of cdkl5 disorder. cdkl5 disorder is a severe, rare genetic disorder that affects children at an early age and causes difficult-to-control seizures and neuro-developmental impairment. currently, there are no approved therapies for children with cdkl5 disorder. orphan drug designation is granted by the fda office of orphan products development to novel drugs or biologics that treat a rare disease or condition affecting fewer than 200,000 patients in the u.s. the designation provides Show More
Quarter analysis & expected interestLast update: November 06 2023 04:40:28.

After 34 days of this quarter the interest is at 48.0. Based on that we can calculate that during remaining 58 days it will total up to 130.0.
Marinus Pharmaceuticals -profile expected interest is significantly higher compared to previous quarter (+209.5%) and same quarter last year (+103.1%).

YearQ1Q2Q3Q4
2018 - - - 28
2019 53
89.3% QoQ
64
20.8% QoQ
110
71.9% QoQ
84
200.0% YoY -23.6% QoQ
2020 46
-13.2% YoY -45.2% QoQ
100
56.2% YoY 117.4% QoQ
256
132.7% YoY 156.0% QoQ
94
11.9% YoY -63.3% QoQ
2021 57
23.9% YoY -39.4% QoQ
61
-39.0% YoY 7.0% QoQ
58
-77.3% YoY -4.9% QoQ
62
-34.0% YoY 6.9% QoQ
2022 85
49.1% YoY 37.1% QoQ
47
-23.0% YoY -44.7% QoQ
70
20.7% YoY 48.9% QoQ
64
3.2% YoY -8.6% QoQ
2023 57
-32.9% YoY -10.9% QoQ
41
-12.8% YoY -28.1% QoQ
42
-40.0% YoY 2.4% QoQ
48
-25.0% YoY 14.3% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Marinus Pharmaceuticals -profile search interestLast update: November 06 2023 04:40:28.
Correlation coefficient between keyword and revenue is -0.29
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 06 2023 04:40:28.

The average 5 years interest of Marinus Pharmaceuticals -profile was 5.87 per week.
The last year interest of Marinus Pharmaceuticals -profile compared to the last 5 years has changed by -30.83%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -24.81%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 03:59:33.

After 39 days of this quarter the interest is at 26.0. Based on that we can calculate that during remaining 52 days it will total up to 61.0.
ganaxolone expected interest is significantly lower compared to previous quarter (-83.3%) and same quarter last year (-63.7%).

YearQ1Q2Q3Q4
2019122
153
25.4% QoQ
202
32.0% QoQ
138
-31.7% QoQ
2020 25
-79.5% YoY -81.9% QoQ
135
-11.8% YoY 440.0% QoQ
228
12.9% YoY 68.9% QoQ
130
-5.8% YoY -43.0% QoQ
2021 23
-8.0% YoY -82.3% QoQ
194
43.7% YoY 743.5% QoQ
192
-15.8% YoY -1.0% QoQ
139
6.9% YoY -27.6% QoQ
2022 208
804.3% YoY 49.6% QoQ
357
84.0% YoY 71.6% QoQ
228
18.8% YoY -36.1% QoQ
176
26.6% YoY -22.8% QoQ
2023 168
-19.2% YoY -4.5% QoQ
154
-56.9% YoY -8.3% QoQ
216
-5.3% YoY 40.3% QoQ
366
108.0% YoY 69.4% QoQ
2024 26
-84.5% YoY -92.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and ganaxolone search interestLast update: February 09 2024 03:59:33.
Correlation coefficient between keyword and revenue is 0.02
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 03:59:35.

The average 5 years interest of ganaxolone was 13.72 per week.
The last year interest of ganaxolone compared to the last 5 years has changed by 9.48%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 26.97%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 03:59:47.

After 39 days of this quarter the interest is at 76.0. Based on that we can calculate that during remaining 52 days it will total up to 177.0.
ZTALMY expected interest is significantly lower compared to same quarter last year (-40.4%) but similar to previous quarter.

YearQ1Q2Q3Q4
201970
194
177.1% QoQ
142
-26.8% QoQ
124
-12.7% QoQ
2020 204
191.4% YoY 64.5% QoQ
74
-61.9% YoY -63.7% QoQ
228
60.6% YoY 208.1% QoQ
118
-4.8% YoY -48.2% QoQ
2021 134
-34.3% YoY 13.6% QoQ
33
-55.4% YoY -75.4% QoQ
87
-61.8% YoY 163.6% QoQ
0
-100.0% YoY -100.0% QoQ
2022 155
15.7% YoY inf% QoQ
158
378.8% YoY 1.9% QoQ
235
170.1% YoY 48.7% QoQ
188
inf% YoY -20.0% QoQ
2023 297
91.6% YoY 58.0% QoQ
291
84.2% YoY -2.0% QoQ
117
-50.2% YoY -59.8% QoQ
171
-9.0% YoY 46.2% QoQ
2024 76
-74.4% YoY -55.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and ZTALMY search interestLast update: February 09 2024 03:59:45.
Correlation coefficient between keyword and revenue is 0.25
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 03:59:49.

The average 5 years interest of ZTALMY was 11.86 per week.
The last year interest of ZTALMY compared to the last 5 years has changed by 21.59%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 27.72%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for rare genetic epilepsies to provide analysis

Correlation between past revenue and rare genetic epilepsies search interest

There is not enough data for rare genetic epilepsies to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for rare genetic epilepsies to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 06 2023 04:40:50.

After 34 days of this quarter the interest is at 225.0. Based on that we can calculate that during remaining 58 days it will total up to 609.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 382
2019 594
55.5% QoQ
516
-13.1% QoQ
619
20.0% QoQ
558
46.1% YoY -9.9% QoQ
2020 604
1.7% YoY 8.2% QoQ
460
-10.9% YoY -23.8% QoQ
577
-6.8% YoY 25.4% QoQ
565
1.3% YoY -2.1% QoQ
2021 551
-8.8% YoY -2.5% QoQ
579
25.9% YoY 5.1% QoQ
512
-11.3% YoY -11.6% QoQ
546
-3.4% YoY 6.6% QoQ
2022 631
14.5% YoY 15.6% QoQ
681
17.6% YoY 7.9% QoQ
685
33.8% YoY 0.6% QoQ
786
44.0% YoY 14.7% QoQ
2023 729
15.5% YoY -7.3% QoQ
739
8.5% YoY 1.4% QoQ
710
3.6% YoY -3.9% QoQ
225
-71.4% YoY -68.3% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and seizure disorders search interestLast update: November 06 2023 04:40:49.
Correlation coefficient between keyword and revenue is 0.28
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 06 2023 04:40:50.

The average 5 years interest of seizure disorders was 47.11 per week.
The last year interest of seizure disorders compared to the last 5 years has changed by 16.88%.
The interest for seizure disorders is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 24.32%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for cyclin-dependent kinase-like 5 deficiency disorder to provide analysis

Correlation between past revenue and cyclin-dependent kinase-like 5 deficiency disorder search interest

There is not enough data for cyclin-dependent kinase-like 5 deficiency disorder to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cyclin-dependent kinase-like 5 deficiency disorder to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for anti-seizure potential to provide analysis

Correlation between past revenue and anti-seizure potential search interest

There is not enough data for anti-seizure potential to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for anti-seizure potential to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for antidepressant potential to provide analysis

Correlation between past revenue and antidepressant potential search interest

There is not enough data for antidepressant potential to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for antidepressant potential to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for anxiolytic potential to provide analysis

Correlation between past revenue and anxiolytic potential search interest

There is not enough data for anxiolytic potential to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for anxiolytic potential to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for PCDH19-related epilepsy to provide analysis

Correlation between past revenue and PCDH19-related epilepsy search interest

There is not enough data for PCDH19-related epilepsy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for PCDH19-related epilepsy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 04:00:00.

After 39 days of this quarter the interest is at 89.0. Based on that we can calculate that during remaining 52 days it will total up to 208.0.
tuberous sclerosis complex expected interest is significantly lower compared to previous quarter (-41.6%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2019152
354
132.9% QoQ
277
-21.8% QoQ
353
27.4% QoQ
2020 291
91.4% YoY -17.6% QoQ
254
-28.2% YoY -12.7% QoQ
299
7.9% YoY 17.7% QoQ
186
-47.3% YoY -37.8% QoQ
2021 224
-23.0% YoY 20.4% QoQ
331
30.3% YoY 47.8% QoQ
198
-33.8% YoY -40.2% QoQ
402
116.1% YoY 103.0% QoQ
2022 219
-2.2% YoY -45.5% QoQ
327
-1.2% YoY 49.3% QoQ
312
57.6% YoY -4.6% QoQ
348
-13.4% YoY 11.5% QoQ
2023 334
52.5% YoY -4.0% QoQ
341
4.3% YoY 2.1% QoQ
304
-2.6% YoY -10.9% QoQ
356
2.3% YoY 17.1% QoQ
2024 89
-73.4% YoY -75.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and tuberous sclerosis complex search interestLast update: February 09 2024 03:59:59.
Correlation coefficient between keyword and revenue is -0.25
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 04:00:01.

The average 5 years interest of tuberous sclerosis complex was 22.8 per week.
The last year interest of tuberous sclerosis complex compared to the last 5 years has changed by 7.72%.
The interest for tuberous sclerosis complex is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by 2.25%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 04:00:08.

After 39 days of this quarter the interest is at 28.0. Based on that we can calculate that during remaining 52 days it will total up to 65.0.
Purdue Neuroscience expected interest is significantly lower compared to previous quarter (-70.6%) and same quarter last year (-66.0%).

YearQ1Q2Q3Q4
201926
49
88.5% QoQ
97
98.0% QoQ
178
83.5% QoQ
2020 142
446.2% YoY -20.2% QoQ
92
87.8% YoY -35.2% QoQ
117
20.6% YoY 27.2% QoQ
164
-7.9% YoY 40.2% QoQ
2021 194
36.6% YoY 18.3% QoQ
95
3.3% YoY -51.0% QoQ
225
92.3% YoY 136.8% QoQ
83
-49.4% YoY -63.1% QoQ
2022 165
-14.9% YoY 98.8% QoQ
80
-15.8% YoY -51.5% QoQ
218
-3.1% YoY 172.5% QoQ
414
398.8% YoY 89.9% QoQ
2023 191
15.8% YoY -53.9% QoQ
17
-78.8% YoY -91.1% QoQ
222
1.8% YoY 1205.9% QoQ
221
-46.6% YoY -0.5% QoQ
2024 28
-85.3% YoY -87.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Purdue Neuroscience search interestLast update: February 09 2024 04:00:08.
Correlation coefficient between keyword and revenue is 0.31
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 04:00:10.

The average 5 years interest of Purdue Neuroscience was 11.56 per week.
The last year interest of Purdue Neuroscience compared to the last 5 years has changed by -1.38%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 45.97%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 04:00:14.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
CyDex Pharmaceuticals expected interest is significantly lower compared to previous quarter (-100.0%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201935
272
677.1% QoQ
118
-56.6% QoQ
77
-34.7% QoQ
2020 28
-20.0% YoY -63.6% QoQ
143
-47.4% YoY 410.7% QoQ
82
-30.5% YoY -42.7% QoQ
98
27.3% YoY 19.5% QoQ
2021 94
235.7% YoY -4.1% QoQ
0
-100.0% YoY -100.0% QoQ
297
262.2% YoY inf% QoQ
120
22.4% YoY -59.6% QoQ
2022 222
136.2% YoY 85.0% QoQ
103
inf% YoY -53.6% QoQ
21
-92.9% YoY -79.6% QoQ
98
-18.3% YoY 366.7% QoQ
2023 0
-100.0% YoY -100.0% QoQ
58
-43.7% YoY inf% QoQ
58
176.2% YoY 0.0% QoQ
37
-62.2% YoY -36.2% QoQ
2024 0
-62.2% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and CyDex Pharmaceuticals search interestLast update: February 09 2024 04:00:14.
Correlation coefficient between keyword and revenue is 0.48
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 04:00:14.

The average 5 years interest of CyDex Pharmaceuticals was 7.51 per week.
The last year interest of CyDex Pharmaceuticals compared to the last 5 years has changed by -60.85%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -69.53%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 04:00:30.

After 39 days of this quarter the interest is at 360.0. Based on that we can calculate that during remaining 52 days it will total up to 840.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019303
490
61.7% QoQ
498
1.6% QoQ
472
-5.2% QoQ
2020 465
53.5% YoY -1.5% QoQ
462
-5.7% YoY -0.6% QoQ
472
-5.2% YoY 2.2% QoQ
468
-0.8% YoY -0.8% QoQ
2021 427
-8.2% YoY -8.8% QoQ
429
-7.1% YoY 0.5% QoQ
415
-12.1% YoY -3.3% QoQ
435
-7.1% YoY 4.8% QoQ
2022 514
20.4% YoY 18.2% QoQ
530
23.5% YoY 3.1% QoQ
546
31.6% YoY 3.0% QoQ
636
46.2% YoY 16.5% QoQ
2023 685
33.3% YoY 7.7% QoQ
731
37.9% YoY 6.7% QoQ
763
39.7% YoY 4.4% QoQ
830
30.5% YoY 8.8% QoQ
2024 360
-47.4% YoY -56.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Orion search interestLast update: February 09 2024 04:00:29.
Correlation coefficient between keyword and revenue is 0.36
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 04:00:32.

The average 5 years interest of Orion was 41.88 per week.
The last year interest of Orion compared to the last 5 years has changed by 40.57%.
The interest for Orion is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 56.65%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Tenacia Biotechnology to provide analysis

Correlation between past revenue and Tenacia Biotechnology search interest

There is not enough data for Tenacia Biotechnology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Tenacia Biotechnology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for MRNS
Earnings date: 2024-03-05 After close
Company name: Marinus Pharmaceuticals Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-10-16T05:00:00.000Z

US FDA
Approval of Ztalmy, Nda #215904 (Efficacy)

2025-10-16T05:00:00.000Z

US FDA
Approval of Ztalmy, Nda #215904 (Labeling)

2025-02-21T08:00:27-05:00

SEC
15-12G Form - Securities registration termination [Section 12(g)] - MARINUS PHARMACEUTICALS, INC. (0001267813) (Filer)

2025-02-14T16:30:03-05:00

SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - MARINUS PHARMACEUTICALS, INC. (0001267813) (Subject)

2025-02-14T16:00:04-05:00

SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - MARINUS PHARMACEUTICALS, INC. (0001267813) (Subject)

2025-02-14T00:15:11-05:00

SEC
EFFECT Form - Notice of Effectiveness - MARINUS PHARMACEUTICALS, INC. (0001267813) (Filer)

2025-02-14T00:15:09-05:00

SEC
EFFECT Form - Notice of Effectiveness - MARINUS PHARMACEUTICALS, INC. (0001267813) (Filer)

2025-02-14T00:15:08-05:00

SEC
EFFECT Form - Notice of Effectiveness - MARINUS PHARMACEUTICALS, INC. (0001267813) (Filer)

2025-02-12T18:40:08-05:00

SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - MARINUS PHARMACEUTICALS, INC. (0001267813) (Subject)

2025-02-11T20:45:32-05:00

SEC
SCHEDULE 13G Form - Statement of Beneficial Ownership by Certain Investors - MARINUS PHARMACEUTICALS, INC. (0001267813) (Subject)

2025-02-11T20:20:29-05:00

SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - MARINUS PHARMACEUTICALS, INC. (0001267813) (Subject)

2025-02-11T11:08:22-05:00

SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - MARINUS PHARMACEUTICALS, INC. (0001267813) (Subject)

2025-02-11T09:19:58-05:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - MARINUS PHARMACEUTICALS, INC. (0001267813) (Issuer)

2025-02-11T09:19:21-05:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - MARINUS PHARMACEUTICALS, INC. (0001267813) (Issuer)

2025-02-11T09:18:26-05:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - MARINUS PHARMACEUTICALS, INC. (0001267813) (Issuer)